Comparative effectiveness and cost-effectiveness of computed tomography screening for coronary artery calcium in asymptomatic individuals

Journal of the American College of Cardiology

Volumn 58, Issue 16, 2011, Pages 1690-1701

  Van Kempen, Bob J H ^a   Spronk, Sandra ^a   Koller, Michael T ^b   Elias Smale, Suzette E ^a   Fleischmann, Kirsten E ^c   Ikram, M Arfan ^a   Krestin, Gabriel P ^a   Hofman, Albert ^a   Witteman, Jacqueline C M ^a   Hunink, M G Myriam ^a,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

coronary heart disease; cost effectiveness analysis; CT coronary calcium; CT screening; primary prevention

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SCREENING TEST; SENSITIVITY ANALYSIS; STROKE;

AGED; CALCIUM; COMPARATIVE EFFECTIVENESS RESEARCH; CORONARY ARTERY DISEASE; CORONARY DISEASE; CORONARY VESSELS; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MARKOV CHAINS; MASS SCREENING; QUALITY OF LIFE; RISK; SEX FACTORS; STROKE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053650216     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2011.05.056     Document Type: Article

References (56)

1. P.W. Wilson, R.B. D'Agostino, D. Levy, A.M. Belanger, H. Silbershatz, and W.B. Kannel Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847 (Pubitemid 28213628)
2. R.B. D'Agostino Sr., R.S. Vasan, and M.J. Pencina General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753 (Pubitemid 351640675)
3. Force USPST Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 150 2009 396 404
4. S.M. Grundy, J.I. Cleeman, and C.N. Merz Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239 (Pubitemid 38924592)
5. T.A. Pearson, S.N. Blair, and S.R. Daniels AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases American Heart Association Science Advisory and Coordinating Committee Circulation 106 2002 388 391 (Pubitemid 34778969)
6. M. Helfand, D.I. Buckley, and M. Freeman Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force Ann Intern Med 151 2009 496 507
7. T.S. Polonsky, R.L. McClelland, and N.W. Jorgensen Coronary artery calcium score and risk classification for coronary heart disease prediction JAMA 303 2010 1610 1616
8. P. Greenland, L. LaBree, S.P. Azen, T.M. Doherty, and R.C. Detrano Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals JAMA 291 2004 210 215 (Pubitemid 38082815)
9. G.T. Kondos, J.A. Hoff, and A. Sevrukov Electron-beam tomography coronary artery calcium and cardiac events: a 37-month follow-up of 5635 initially asymptomatic low- to intermediate-risk adults Circulation 107 2003 2571 2576 (Pubitemid 36628938)
10. Y. Arad, K.J. Goodman, M. Roth, D. Newstein, and A.D. Guerci Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study J Am Coll Cardiol 46 2005 158 165 (Pubitemid 40905145)
11. A.J. Taylor, J. Bindeman, I. Feuerstein, F. Cao, M. Brazaitis, and P.G. O'Malley Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project J Am Coll Cardiol 46 2005 807 814 (Pubitemid 41224803)
12. R. Vliegenthart, M. Oudkerk, and A. Hofman Coronary calcification improves cardiovascular risk prediction in the elderly Circulation 112 2005 572 577 (Pubitemid 41060798)
13. M.J. LaMonte, S.J. FitzGerald, and T.S. Church Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women Am J Epidemiol 162 2005 421 429 (Pubitemid 41191427)
14. T.S. Church, B.D. Levine, and D.K. McGuire Coronary artery calcium score, risk factors, and incident coronary heart disease events Atherosclerosis 190 2007 224 231 (Pubitemid 44908322)
15. M.J. Budoff, L.J. Shaw, and S.T. Liu Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients J Am Coll Cardiol 49 2007 1860 1870 (Pubitemid 46661110)
16. R. Detrano, A.D. Guerci, and J.J. Carr Coronary calcium as a predictor of coronary events in four racial or ethnic groups N Engl J Med 358 2008 1336 1345 (Pubitemid 351468410)
17. S. Elias-Smale, R.V. Proena, and M.T. Koller Coronary calcium score improves classification of coronary heart disease risk in elderly: the Rotterdam study J Am Coll Cardiol 56 2010 1407 1414
18. N.R. Cook, and P.M. Ridker Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures Ann Intern Med 150 2009 795 802
19. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion 20712 (Pubitemid 351193639)
20. M.J. Pletcher, and M. Pignone Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact Circulation 123 2011 1116 1124
21. A.V. Chobanian, G.L. Bakris, and H.R. Black The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2003 2560 2572 (Pubitemid 37430158)
22. A.S. Adabag, T.M. Therneau, B.J. Gersh, S.A. Weston, and V.L. Roger Sudden death after myocardial infarction JAMA 300 2008 2022 2029
23. J.S. Berger, M.C. Roncaglioni, F. Avanzini, I. Pangrazzi, G. Tognoni, and D.L. Brown Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials JAMA 295 2006 306 313
24. J.J. Brugts, T. Yetgin, and S.E. Hoeks The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials BMJ 338 2009 b2376
25. M.J. de Boer, B.A. van Hout, A.L. Liem, H. Suryapranata, J.C. Hoorntje, and F. Zijlstra A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction Am J Cardiol 76 1995 830 833
26. J.W. Deckers, D.M. Goedhart, and E. Boersma Treatment benefit by perindopril in patients with stable coronary artery disease at different levels of risk Eur Heart J 27 2006 796 801
27. A.J. Einstein, M.J. Henzlova, and S. Rajagopalan Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography JAMA 298 2007 317 323 (Pubitemid 47080486)
28. J.P. Greving, E. Buskens, H. Koffijberg, and A. Algra Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk Circulation 117 2008 2875 2883 (Pubitemid 351787070)
29. K.P. Kim, A.J. Einstein, and A. Berrington de Gonzalez Coronary artery calcification screening: estimated radiation dose and cancer risk Arch Intern Med 169 2009 1188 1194
30. M.R. Law, J.K. Morris, and N.J. Wald Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies BMJ 338 2009 b1665
31. S. Lightowlers, and A. McGuire Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke Stroke 29 1998 1827 1832 (Pubitemid 28399972)
32. J.A. Nyman, N.A. Barleen, B.E. Dowd, D.W. Russell, S.J. Coons, and P.W. Sullivan Quality-of-life weights for the US population: self-reported health status and priority health conditions, by demographic characteristics Med Care 45 2007 618 628
33. T. Rice Red Book 2009: Pharmacy's Fundamental Reference (Red Book Drug Topics) 2009 Thomson Reuters Montvale, New Jersey
34. S.D. Saini, P. Schoenfeld, A.M. Fendrick, and J. Scheiman Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention Arch Intern Med 168 2008 1684 1690 discussion 1691
35. A. Hofman, M.M. Breteler, and C.M. van Duijn The Rotterdam Study: 2010 objectives and design update Eur J Epidemiol 24 2009 553 572
36. S.E. Elias-Smale, A.E. Odink, and R.G. Wieberdink Carotid, aortic arch and coronary calcification are related to history of stroke: the Rotterdam study Atherosclerosis 212 2010 656 660
37. World Health Organization Life tables for WHO Member States http://www.who.int/healthinfo/statistics/mortality-life-tables/en/ Accessed August 26, 2011
38. C. Baigent, L. Blackwell, and R. Collins Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials Lancet 373 2009 1849 1860
39. P.M. Ho, C.L. Bryson, and J.S. Rumsfeld Medication adherence: its importance in cardiovascular outcomes Circulation 119 2009 3028 3035
40. N.J. Wald, and M.R. Law A strategy to reduce cardiovascular disease by more than 80% BMJ 326 2003 1419
41. S. Yusuf, P. Pais Indian Polycap Study (TIPS) Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial Lancet 373 2009 1341 1351
42. M. Law, and A.R. Rudnicka Statin safety: a systematic review Am J Cardiol 97 2006 52C 60C
43. M.J. Pletcher, L. Lazar, and K. Bibbins-Domingo Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering Ann Intern Med 150 2009 243 254
44. J. Ma, K.V. Lee, and R.S. Stafford Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004 Hypertension 48 2006 846 852 (Pubitemid 44610996)
45. T.L. Kauf, E.J. Velazquez, and D.R. Crosslin The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry Am Heart J 151 2006 206 212 (Pubitemid 41815357)
46. J. Tsevat, K.M. Kuntz, E.J. Orav, M.C. Weinstein, F.M. Sacks, and L. Goldman Cost-effectiveness of pravastatin therapy for survivors of myocardial infarction with average cholesterol levels Am Heart J 141 2001 727 734 (Pubitemid 32378480)
47. H. Gravelle, W. Brouwer, L. Niessen, M. Postma, and F. Rutten Discounting in economic evaluations: stepping forward towards optimal decision rules Health Econ 16 2007 307 317 (Pubitemid 46431778)
48. J.E. Siegel, M.C. Weinstein, L.B. Russell, and M.R. Gold Recommendations for reporting cost-effectiveness analyses Panel on Cost-Effectiveness in Health and Medicine JAMA 276 1996 1339 1341 (Pubitemid 26346934)
49. P.S. Corso, J.K. Hammitt, J.D. Graham, R.C. Dicker, and S.J. Goldie Assessing preferences for prevention versus treatment using willingness to pay Med Decis Making 22 2002 S92 S101
50. R.A. Hirth, M.E. Chernew, E. Miller, A.M. Fendrick, and W.G. Weissert Willingness to pay for a quality-adjusted life year: in search of a standard Med Decis Making 20 2000 332 342 (Pubitemid 30479101)
51. K.K. Lee, L.E. Cipriano, D.K. Owens, A.S. Go, and M.A. Hlatky Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy Circulation 122 2010 1478 1487
52. M.G. Myrium Hunink, P.P. Glasziou, and J.E. Siegel Decision Making in Health and Medicine: Integrating Evidence and Values 2001 Cambridge University Press Cambridge, United Kingdom
53. P.G. O'Malley, B.A. Greenberg, and A.J. Taylor Cost-effectiveness of using electron beam computed tomography to identify patients at risk for clinical coronary artery disease Am Heart J 148 2004 106 113 (Pubitemid 38900490)
54. J.A. Rumberger Cost effectiveness of coronary calcification scanning using electron beam tomography in intermediate and high risk asymptomatic individuals J Cardiovasc Risk 7 2000 113 119 (Pubitemid 30399074)
55. L.J. Shaw, P. Raggi, D.S. Berman, and T.Q. Callister Cost effectiveness of screening for cardiovascular disease with measures of coronary calcium Prog Cardiovasc Dis 46 2003 171 184 (Pubitemid 37163345)
56. S.R. Earnshaw, J. Scheiman, A.M. Fendrick, C. McDade, and M. Pignone Cost-utility of aspirin and proton pump inhibitors for primary prevention Arch Intern Med 171 2011 218 225